Pages that link to "Q44002202"
Jump to navigation
Jump to search
The following pages link to Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis (Q44002202):
Displaying 50 items.
- Cancer Stem Cells and Their Interaction with the Tumor Microenvironment in Neuroblastoma (Q26771238) (← links)
- Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome (Q26853083) (← links)
- Profile of minocycline and its potential in the treatment of schizophrenia (Q26864400) (← links)
- Synaptic circuit remodelling by matrix metalloproteinases in health and disease (Q27005718) (← links)
- The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis (Q27009126) (← links)
- Nitric Oxide Protects against Infection-Induced Neuroinflammation by Preserving the Stability of the Blood-Brain Barrier (Q27315919) (← links)
- Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline (Q27342233) (← links)
- Update on the treatment of spinal cord injury (Q28235777) (← links)
- The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting (Q28299076) (← links)
- Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease (Q28482356) (← links)
- Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII (Q28576309) (← links)
- Inflammation is detrimental for neurogenesis in adult brain (Q29619040) (← links)
- Extrapontine myelinolysis in an 18-month-old boy with diabetic ketoacidosis: case report and literature review (Q30762831) (← links)
- Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease (Q30847955) (← links)
- Emerging therapies in multiple sclerosis (Q31015100) (← links)
- Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. (Q33198766) (← links)
- A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis (Q33367112) (← links)
- PEG minocycline-liposomes ameliorate CNS autoimmune disease (Q33398048) (← links)
- Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets (Q33843008) (← links)
- The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease. (Q33898964) (← links)
- Cancer associated fibroblasts (CAFs) in tumor microenvironment (Q33999773) (← links)
- New oral disease-modifying therapies for multiple sclerosis (Q34076398) (← links)
- Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. (Q34109028) (← links)
- Minocycline inhibits alkali burn-induced corneal neovascularization in mice (Q34359185) (← links)
- Minocycline Prevents Osmotic Demyelination Syndrome by Inhibiting the Activation of Microglia (Q34457152) (← links)
- Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells--implications for complementary multiple sclerosis treatment (Q34581020) (← links)
- Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha). (Q34610688) (← links)
- The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study (Q34623345) (← links)
- Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice (Q34659673) (← links)
- Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cells (Q34719602) (← links)
- Reversible neural stem cell niche dysfunction in a model of multiple sclerosis. (Q34861360) (← links)
- Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies (Q35094706) (← links)
- Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis (Q35103843) (← links)
- Immunotherapy in autoimmune neuromuscular disorders (Q35172337) (← links)
- Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial (Q35215604) (← links)
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). (Q35589934) (← links)
- Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis (Q35592638) (← links)
- Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents (Q35774581) (← links)
- Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial (Q35789318) (← links)
- Combination therapy for multiple sclerosis: the treatment strategy of the future? (Q35891544) (← links)
- Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline. (Q35901927) (← links)
- The promise of minocycline in neurology. (Q35958974) (← links)
- Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess (Q36007420) (← links)
- Minocycline as a neuroprotective agent (Q36215217) (← links)
- Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis (Q36228251) (← links)
- Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis (Q36299405) (← links)
- Metalloproteinases: mediators of pathology and regeneration in the CNS. (Q36313201) (← links)
- Oxidative and nitrative stress in neurodegeneration (Q36326881) (← links)
- The immune system and neuropsychiatric diseases (Q36364186) (← links)
- Minocycline for short-term neuroprotection (Q36428406) (← links)